Home » Tender for The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement Under § 130a Abs. 8 Sgb V For The Active Ingredient Mesalazine (excluding Dafo Rsu + Kli), Atc A07ec02 For The Period From 01.06.2026 To 31.05.2028, With An Option To Extend For 1x1, Germany